4.45
-0.05 (-1.11%)
| 前收盘价格 | 4.50 |
| 收盘价格 | 4.46 |
| 成交量 | 226,001 |
| 平均成交量 (3个月) | 702,084 |
| 市值 | 289,403,744 |
| 价格/销量 (P/S) | 1.41 |
| 股市价格/股市净资产 (P/B) | 4.32 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2026 |
| 营业毛利率 | -25.14% |
| 营业利益率 (TTM) | -29.64% |
| 稀释每股收益 (EPS TTM) | -0.850 |
| 季度收入增长率 (YOY) | 2.90% |
| 总债务/股东权益 (D/E MRQ) | 65.85% |
| 流动比率 (MRQ) | 4.50 |
| 营业现金流 (OCF TTM) | -25.75 M |
| 杠杆自由现金流 (LFCF TTM) | -17.03 M |
| 资产报酬率 (ROA TTM) | -14.56% |
| 股东权益报酬率 (ROE TTM) | -45.73% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Treace Medical Concepts, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | -1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.13 |
|
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 25.76% |
| 机构持股比例 | 62.73% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Gagnon Advisors, Llc | 30 Jun 2026 | 1,534,034 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合